ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

WINT Windtree Therapeutics Inc

5.00
-0.30 (-5.66%)
Apr 30 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 25,945
Bid Price 4.96
Ask Price 5.54
News -
Day High 5.38

Low
4.7772

52 Week Range

High
35.10

Day Low 5.02
Share Name Share Symbol Market Stock Type
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.30 -5.66% 5.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
5.38 5.02 5.38 5.065 5.30
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,834 25,945 US$ 5.20 US$ 135,020 - 4.7772 - 35.10
Last Trade Type Quantity Price Currency
18:59:39 1 US$ 4.98 USD

Windtree Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
26.05M 5.15M - 0 -20.29M -3.94 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Windtree Therapeutics News

Date Time Source News Article
4/18/202407:00GlobeNewswire Inc.Windtree Therapeutics Announces Reverse Stock Split
4/17/202407:00GlobeNewswire Inc.Windtree Therapeutics Reports Fourth Quarter and Year-End..
4/08/202415:48GlobeNewswire Inc.Windtree Acquires Early-Stage, Novel Oncology Platform and..
2/16/202416:07Edgar (US Regulatory)Form 8-K - Current report
2/14/202416:23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
2/14/202415:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202419:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202415:40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
2/01/202416:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/01/202407:00GlobeNewswire Inc.Windtree Renews Agreement with Chang Gung University for..
1/31/202407:40InvestorsHub NewsWireWindtree Therapeutics Announces Engagement of Strategic..
1/31/202407:00Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No WINT Message Board. Create One! See More Posts on WINT Message Board See More Message Board Posts

Historical WINT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.385.904.835.3943,516-0.38-7.06%
1 Month6.6428.69584.77726.67260,894-1.64-24.72%
3 Months6.67628.69584.77726.58155,990-1.68-25.11%
6 Months18.5422.36144.77729.42213,941-13.54-73.03%
1 Year27.3635.104.777218.76237,807-22.36-81.73%
3 Years2,016.003,060.004.7772900.301,019,028-2,011.00-99.75%
5 Years6,255.009,054.004.7772993.60806,864-6,250.00-99.92%

Windtree Therapeutics Description

Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactants without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF which is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.

Your Recent History

Delayed Upgrade Clock